RISP 3MG TAB is an atypical antipsychotic tablet formulation delivering 3mg of risperidone per dose for management of psychotic and mood disorders. This oral medication provides balanced dopaminergic and serotonergic modulation, effectively addressing positive and negative symptoms of schizophrenia, bipolar disorder, and related psychiatric conditions. The 3mg strength represents a clinically validated dosing level optimizing therapeutic response while maintaining favorable tolerability profiles. RISP offers predictable pharmacokinetics and consistent symptom control, supporting functional recovery and improved quality of life in patients with severe mental illness. Administered under psychiatric supervision, this formulation delivers reliable antipsychotic efficacy with established safety monitoring protocols, making it a cornerstone agent in contemporary psychopharmacological practice.

RISP 1MG TAB